Drug decision reversal offers hope for cancer sufferers

People with a rare form of cancer which occurs in the muscles, nerves, fat or blood vessels could benefit from a new treatment, it was announced today.

The National Institute for Health and Clinical Excellence (Nice) in Britain has reversed an earlier decision on the drug trabectedin after the manufacturers agreed to a cost-reducing scheme.